38 related articles for article (PubMed ID: 23404675)
1. Lessons from common markers of tumor-initiating cells in solid cancers.
Gires O
Cell Mol Life Sci; 2011 Dec; 68(24):4009-22. PubMed ID: 21786143
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.
Qureshi-Baig K; Ullmann P; Haan S; Letellier E
Mol Cancer; 2017 Feb; 16(1):40. PubMed ID: 28209178
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.
Cermeño EA; García AJ
Curr Stem Cell Rep; 2016 Mar; 2(1):21-32. PubMed ID: 27141429
[TBL] [Abstract][Full Text] [Related]
4. Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells.
Benguigui M; Weitz IS; Timaner M; Kan T; Shechter D; Perlman O; Sivan S; Raviv Z; Azhari H; Shaked Y
Sci Rep; 2019 Aug; 9(1):12613. PubMed ID: 31471546
[TBL] [Abstract][Full Text] [Related]
5. Targeting prostate cancer cell proliferation, stemness and metastatic potential using
Elkady AI
Am J Transl Res; 2019; 11(4):2550-2569. PubMed ID: 31105862
[TBL] [Abstract][Full Text] [Related]
6. Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.
Timaner M; Letko-Khait N; Kotsofruk R; Benguigui M; Beyar-Katz O; Rachman-Tzemah C; Raviv Z; Bronshtein T; Machluf M; Shaked Y
Cancer Res; 2018 Mar; 78(5):1253-1265. PubMed ID: 29301792
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between M2 macrophages and glioma stem cells.
Nusblat LM; Carroll MJ; Roth CM
Cell Oncol (Dordr); 2017 Oct; 40(5):471-482. PubMed ID: 28643230
[TBL] [Abstract][Full Text] [Related]
8. Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling.
Al-Wadei MH; Banerjee J; Al-Wadei HA; Schuller HM
Eur J Cancer; 2016 Jan; 52():188-96. PubMed ID: 26689865
[TBL] [Abstract][Full Text] [Related]
9. Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides.
Banerjee J; Papu John AM; Schuller HM
Int J Cancer; 2015 Dec; 137(12):2815-24. PubMed ID: 26088878
[TBL] [Abstract][Full Text] [Related]
10. Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.
Park SC; Zeng C; Tschudy-Seney B; Nguyen NT; Eun JR; Zhang Y; Ramsamooj R; Zhang Y; Zhao M; Theise ND; Zhou H; Zern MA; Duan Y
Stem Cells Dev; 2015 Jul; 24(13):1506-14. PubMed ID: 25867583
[TBL] [Abstract][Full Text] [Related]
11. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.
Burkhart C; Fleyshman D; Kohrn R; Commane M; Garrigan J; Kurbatov V; Toshkov I; Ramachandran R; Martello L; Gurova KV
Oncotarget; 2014 Nov; 5(22):11038-53. PubMed ID: 25402820
[TBL] [Abstract][Full Text] [Related]
12. A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
Kast RE; Boockvar JA; Brüning A; Cappello F; Chang WW; Cvek B; Dou QP; Duenas-Gonzalez A; Efferth T; Focosi D; Ghaffari SH; Karpel-Massler G; Ketola K; Khoshnevisan A; Keizman D; Magné N; Marosi C; McDonald K; Muñoz M; Paranjpe A; Pourgholami MH; Sardi I; Sella A; Srivenugopal KS; Tuccori M; Wang W; Wirtz CR; Halatsch ME
Oncotarget; 2013 Apr; 4(4):502-30. PubMed ID: 23594434
[TBL] [Abstract][Full Text] [Related]
13. Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugs.
Benayoun L; Gingis-Velitski S; Voloshin T; Segal E; Segev R; Munster M; Bril R; Satchi-Fainaro R; Scherer SJ; Shaked Y
Stem Cells; 2012 Sep; 30(9):1831-41. PubMed ID: 22782858
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.
Michishita M; Otsuka A; Nakahira R; Nakagawa T; Sasaki N; Arai T; Takahashi K
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):73-81. PubMed ID: 24041801
[TBL] [Abstract][Full Text] [Related]
15. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.
Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X
J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344
[TBL] [Abstract][Full Text] [Related]
16. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
[TBL] [Abstract][Full Text] [Related]
17. Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells.
Khan MI; Czarnecka AM; Helbrecht I; Bartnik E; Lian F; Szczylik C
Stem Cell Res Ther; 2015 Sep; 6(1):178. PubMed ID: 26377541
[TBL] [Abstract][Full Text] [Related]
18. In vitro enrichment of tumor-initiating cells from human established cell lines.
Benayoun L; Shaked Y
Curr Protoc Stem Cell Biol; 2013 Feb; Chapter 3():Unit 3.7. PubMed ID: 23404675
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
